Equities

Touyun Biotech Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Touyun Biotech Group Ltd

Actions
  • Price (HKD)0.115
  • Today's Change-0.012 / -9.45%
  • Shares traded1.55m
  • 1 Year change-32.35%
  • Beta-0.2216
Data delayed at least 15 minutes, as of Feb 16 2026 03:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, is an investment holding company principally engaged in the manufacture and sales of packaging products. Along with subsidiaries, the Company operates its business through four segments. The Packaging Products segment is engaged in the production and sale of manufacture and sale of watch boxes, jewelry boxes, eyewear cases, bags and pouches and display units. The Quick Response (QR) Code Business segment is engaged in the provision of QR code on product packaging and solutions and advertising display services. The Chlamydomonas Reinhardtii Product Business segment is engaged in the production and sale of chlamydomonas reinhardtii, micro-algae and related products. The Treasury Investment segment is engaged in the investments and trading in securities, money lending, securities brokerage and margin financing.

  • Revenue in HKD (TTM)117.22m
  • Net income in HKD-23.20m
  • Incorporated2011
  • Employees465.00
  • Location
    Touyun Biotech Group Ltd7th Floor, China United Centre28 Marble Road, North Point Hong KongHKG
  • Phone+852 22707200
  • Fax+852 22719311
  • Websitehttps://touyunbiotech.com.hk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.